posted on 2018-11-23, 00:00authored byYilong Cheng, Gary W. Liu, Ritika Jain, Jeffrey W. Pippin, Stuart J. Shankland, Suzie H. Pun
We
report an acid-reversible linker for triggered release of Bis-T-23,
an experimental small molecule drug for kidney disease treatment that
restores podocyte morphology during disease. Bis-T-23 contains catechols,
which form an acid-reversible, covalent boronate ester bond with boronic
acids. We synthesized phenylboronic acid-containing polymers using
reversible addition–fragmentation chain transfer polymerization
that were able to directly load and solubilize Bis-T-23. Because of
the reversibility of the boronic ester bond, drug was released in
its native form in a pH-dependent manner. The polymers rapidly trafficked
into acidic compartments and did not exhibit cytotoxicity, and polymer-drug
conjugates successfully delivered Bis-T-23 into cultured podocytes.